CANCER, AIDS, and HOSPICE CARE

A collection of Journal articles and formulations within one or more related compounding topics.

This archive contains the following articles listed by volume, issue and page number:

CANCER AND AIDS RELATED ARTICLES

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2024 Pg. 278-281	Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site Author(s): Wood Robert M
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 316	Calculations Author(s): Stockton Shelly J
Jan/Feb 2022 Pg. 6-8	Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 235	Temozolomide 10 mg/mL in Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Author(s): Hui Ada, Yin Jian, Liu Wei, Zheng Kai
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jan/Feb 2020 Pg. 52	Calculations Author(s): Stockton Shelly J
Jan/Feb 2020 Pg. 83-85	Compatibility of Melphalan in Iodinated Contrast Media Author(s): Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 417-423	Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Jul/Aug 2018 Pg. 314	Calculations Author(s): Stockton Shelly J
Jul/Aug 2018 Pg. 318	Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 345-349	Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Author(s): Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Author(s): Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Nov/Dec 2016 Pg. 508	Erlotinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 511	Lapatinib Ditosylate 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 405	Calculations Author(s): Stockton Shelly J
Jul/Aug 2016 Pg. 327	Tretinoin 10-mg Oral Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Nov/Dec 2015 Pg. 502	Calculations Author(s): Stockton Shelly J
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 238	Methotrexate 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 240	Tamoxifen 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 148	Secretin 4 mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 63	Lomustine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Nov/Dec 2013 Pg. 506	Metyrosine 250-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 262-263	PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Author(s): Williams LaVonn A
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 498-499	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
Sep/Oct 2012 Pg. 431-433	Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Sep/Oct 2012 Pg. 434-437	Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Author(s): Radojkovic Branko, Milic Jela, Calija Bojan
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Jan/Feb 2012 Pg. 82-85	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jan/Feb 2012 Pg. 22-33	Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Author(s): Zur Eyal
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 515-520	Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Author(s): Kaiser Jeanette, Kramer Irene
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 428-434	Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Author(s): Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 428	Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 210-213	Potential Treatments for Radiation Dermatitis Author(s): Corsini Lindsay
May/Jun 2010 Pg. 245	Cyclophosphamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 248	Sunitinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 100-104	Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Author(s): Biundo Bruce
Mar/Apr 2010 Pg. 118-123	Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Author(s): McElhiney Linda F
Sep/Oct 2009 Pg. 434	Mechlorethamine Hydrochloride 0.02% Topical Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 435	Myristyl Nicotinate 5% Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 153	Aprepitant 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 155	Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 156	Ionic Hydration Solution for Anti-Cancer Therapy Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
Jul/Aug 2008 Pg. 361	Tretinoin and Dexpanthenol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 2008 Pg. 16-27	Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 62	Calculations: Compounding for Cancer Patients Author(s): Stockton Shelly J
Jul/Aug 2007 Pg. 336	Temozolomide 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 212-218	Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Author(s): McNulty Jack P
Mar/Apr 2007 Pg. 155	Busulfan 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 158	Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 160	Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Jan/Feb 2007 Pg. 82-85	Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2006 Pg. 454	Cyclophosphamide 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 336-342	Dermatological Effects from Years in the Sun: Compounding Opportunities Author(s): Jones Marty
Sep/Oct 2006 Pg. 384	Hydroxyurea 100 mg/mL Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 385	Indinavir 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 396-399	Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Author(s): Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
Jul/Aug 2006 Pg. 305	Rifabutin 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 222	Granisetron 0.05-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 224	Mesna 20-mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
Jan/Feb 2006 Pg. 59	Chlorambucil 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 62	Efavirenz 20-mg/mL Oral Liquid, Anhydrous Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 64	Mercaptopurine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 68	Thioguanine 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 312	Brompton's Mixture Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 320-322	Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Author(s): Trissel Lawrence A, Zhang Yanping
May/Jun 2005 Pg. 195-198	Compounding Antiangiogenic Cancer Therapy for Animals Author(s): Davidson Gigi S
May/Jun 2005 Pg. 234	Piroxicam 2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
Sep/Oct 2004 Pg. 324-327	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E, MacLean Lindsay
Sep/Oct 2004 Pg. 383	Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 244-249	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
Jul/Aug 2004 Pg. 296	Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 218	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 140	Stomatitis Mouthwash Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 141	Tacrolimus 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 386-388	Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Author(s): Gupta Vishnu D
May/Jun 2003 Pg. 183	ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 250-254	The Hormonal Link to Breast Cancer: The Estrogen Matrix Author(s): Zava David T
Mar/Apr 2002 Pg. 140-141	Sterilization of Talc for Use in Pleurodesis Author(s): Fehr Richard, Henke Michelle, Ashworth Lisa D
Jul/Aug 2001 Pg. 268-271	Antineoplastic Agents Author(s): Ashworth Lisa D
Jul/Aug 2001 Pg. 320-322	A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes Author(s): Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
May/Jun 2001 Pg. 209	Mitomycin 0.02% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 51	Promethazine HCl 50-mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 334	Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Author(s): Mathews Elizabeth
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 257-260	Surviving Cancer - How the Compounding Pharmacist Can Help Author(s): Maddox Suzan
Jul/Aug 2000 Pg. 264-272	Providing Positive Outcomes through Compounding for Animal Cancer Patients Author(s): Davidson Gigi S
Jul/Aug 2000 Pg. 296	Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 298	Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 302	Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 305	Ondansetron HCl 8-mg/mL in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 320-323	Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Author(s): Fuhrman L Clifton, Godwin Donald A, Davis R Alan
Sep/Oct 1999 Pg. 380-381	Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Author(s): Glasnapp Andrew
Sep/Oct 1999 Pg. 381	Tamoxifen Citrate Cream 0.1% Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 241-244	Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
Jan/Feb 1999 Pg. 10	Oral Ulceration Mouthwash Author(s): Allen Loyd V Jr
Jan/Feb 1999 Pg. 67-68	Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Author(s): Lieu Cynthia L, Chin Alfred, Gill Mark A
Nov/Dec 1998 Pg. 414-415	Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Author(s): Paoletti James E, Benavides Tomas J
Sep/Oct 1998 Pg. 382-384	Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Author(s): Xu Quanyun A, Trissel Lawrence A
Jul/Aug 1998 Pg. 300	Fluorouracil 5% Topical Stick Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 243-245	Paclitaxel Compatibility with IV Express Filter Unit Author(s): Xu Quanyun A, Trissel Lawrence A, Zhang Yanping
Jan/Feb 1998 Pg. 21-23	Estrogen and Breast Cancer: Is There a Link? Author(s): Gever Marcy Portnoff
Jan/Feb 1998 Pg. 83-88	Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Jan/Feb 1998 Pg. 89-91	Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Author(s): Zhang Yanping, Trissel Lawrence A, Johansen Jamie F, Kimball Carol L
Nov/Dec 1997 Pg. 386-388	Compounding Pharmacists Play a Vital Role in AIDS Treatment Author(s): Staton Tracy
Sep/Oct 1997 Pg. 324	Doxorubicin HCl-Vincristine Sulfate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 326	Granisetron HCl-Dexamethasone Sodium Phosphate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 328	Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 332	Ondansetron HCl-Dexamethasone Sodium Phosphate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 333	Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 334	Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations) Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 282-283	Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Author(s): Gupta Vishnu D, Maswoswe J
May/Jun 1997 Pg. 175	Antiemetic Injection for Cancer Chemotherapy Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 12	Rectal and Stomal Administration of Analgesic Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 18-19	Aromatherapy and the Hospice Patient Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 26	ABH Hard Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Soft Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Sugar Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 28	Antiemetic Suppositories of the Gralla Type Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen-Modified Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 34-35	Ondansetron HCl Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 37	Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 38	Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 49-53	Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Author(s): Trissel Lawrence A, Xu Quanyun, Martinez Juan F

HOSPICE/PALLIATIVE CARE RELATED ARTICLES

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2024 Pg. 278-281	Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site Author(s): Wood Robert M
Jul/Aug 2022 Pg. 302-307	Basics: Hollow-type Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 330-335	Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions Author(s): Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Jan/Feb 2020 Pg. 56	Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Nov/Dec 2012 Pg. 452-455	Palliative Care and Compounding for Household Pets Author(s): Gaskins Jessica L
Sep/Oct 2012 Pg. 364-368	Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Author(s): McNulty Jack P, Hahn Kristian
Jan/Feb 2010 Pg. 6-8	When Traditional Medicine Fails Author(s): Bash Robert
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
May/Jun 2008 Pg. 182-190	Topical Treatment of Neuropathic Pain Author(s): Vadaurri Vince
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
Jul/Aug 2006 Pg. 293-295	Aseptic Compounding in New Zealand and the Use of Still Air Boxes Author(s): Gargiulo Derryn, Kairuz Therese Eileen
Mar/Apr 2006 Pg. 147-153	Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
Mar/Apr 2006 Pg. 100-102	The Story of Hospice Author(s): Kuntz Rachael
Mar/Apr 2006 Pg. 103-106	The Dying Process Author(s): Fonseca Simonne C
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
May/Jun 2004 Pg. 185	Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2003 Pg. 375	Indomethacin 50-mg Suppositories Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 183	ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 289-293	Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Mar/Apr 1998 Pg. 111-114	Managing Pain in the Terminally Ill Author(s): Williams Clifford L
Mar/Apr 1998 Pg. 116-117	The Symptom Relief Kit for Hospice Patients Author(s): Petrin Ronald L
Nov/Dec 1997 Pg. 386-388	Compounding Pharmacists Play a Vital Role in AIDS Treatment Author(s): Staton Tracy
Jan/Feb 1997 Pg. 10-12	Hospice Care and the Pharmacist Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 12	Rectal and Stomal Administration of Analgesic Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 18-19	Aromatherapy and the Hospice Patient Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 20	Aromatherapy Mood Elevation No. 1 Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 21	Aromatherapy Mood Elevation No. 2 Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 26	ABH Hard Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Soft Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Sugar Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 32-33	Morphine Sulfate Slow-Release Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 34-35	Ondansetron HCl Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 36	Morphine Suppositories Author(s): Allen Loyd V Jr